Albireo Pharma Cost of Revenue | ALBO

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
1.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.36 M	1.36 M	1.36 M

Quarterly Cost of Revenue Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	612 K	776 K	234 K	-	431 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
776 K	234 K	513 K

Cost of Revenue of other stocks in the Biotechnology industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
AbbVie ABBV	18.2 B	$ 257.12	0.86 %	$ 455 B	USA
Ayala Pharmaceuticals AYLA	602 K	-	-	$ 7.46 M	Israel
Amryt Pharma plc AMYT	106 M	-	-	$ 621 M	Britain
ASLAN Pharmaceuticals Limited ASLN	407 K	-	-14.27 %	$ 1.7 M	Singapore
Acorda Therapeutics ACOR	15.3 M	-	-24.86 %	$ 820 K	USA
Adaptimmune Therapeutics plc ADAP	70 K	-	-15.15 %	$ 60.3 M	Britain
Advaxis ADXS	13 K	-	-9.65 %	$ 45.9 M	USA
Abeona Therapeutics ABEO	1.53 M	$ 5.42	0.18 %	$ 287 M	USA
BioXcel Therapeutics BTAI	164 K	$ 0.07	9.81 %	$ 855 K	USA
Lexicon Pharmaceuticals LXRX	274 K	$ 2.0	0.3 %	$ 726 M	USA
Ampio Pharmaceuticals AMPE	244 K	-	-11.43 %	$ 502 K	USA
ACADIA Pharmaceuticals ACAD	89 M	$ 27.83	0.32 %	$ 4.69 B	USA
Berkeley Lights BLI	24.8 M	-	-7.31 %	$ 87 M	USA
Baudax Bio BXRX	7.01 M	-	0.59 %	$ 63 K	USA
Avid Bioservices CDMO	133 M	-	-	$ 789 M	USA
Aclaris Therapeutics ACRS	2.09 M	$ 5.32	1.27 %	$ 652 M	USA
ADC Therapeutics SA ADCT	5.8 M	$ 1.07	0.45 %	$ 136 M	Schweiz
ADMA Biologics ADMA	217 M	$ 9.23	0.16 %	$ 2.2 B	USA
Adaptive Biotechnologies Corporation ADPT	71.4 M	$ 24.2	0.08 %	$ 3.67 B	USA
Agenus AGEN	1.02 M	$ 6.94	0.73 %	$ 206 M	USA
Agios Pharmaceuticals AGIO	6.34 M	$ 33.6	0.16 %	$ 1.95 B	USA